Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers

CONCLUSION: The combined use of s-RalA-Abs and s-p53-Abs tended to increase the positivity rate in all cancers, including Stage 0/I/II cancers.PMID:34632560 | DOI:10.1007/s10147-021-02045-0
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Source Type: research